Page last updated: 2024-11-08

amifampridine and Neuromuscular Blockade

amifampridine has been researched along with Neuromuscular Blockade in 2 studies

Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.

Neuromuscular Blockade: The intentional interruption of transmission at the NEUROMUSCULAR JUNCTION by external agents, usually neuromuscular blocking agents. It is distinguished from NERVE BLOCK in which nerve conduction (NEURAL CONDUCTION) is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce MUSCLE RELAXATION as an adjunct to anesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anesthesia but is grouped here with anesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Friggeri, A1
Marçon, F1
Marciniak, S1
Lemaire-Hurtel, AS1
Seydi, A1
Ammenouche, N1
Levrard, M1
Mahjoub, Y1
Airapetian, N1
Tinturier, F1
Petitjean, M1
Dupont, H1
Morbiato, L1
Carli, L1
Johnson, EA1
Montecucco, C1
Molgó, J1
Rossetto, O1

Trials

1 trial available for amifampridine and Neuromuscular Blockade

ArticleYear
3,4-Diaminopyridine may improve neuromuscular block during botulism.
    Critical care (London, England), 2013, Sep-05, Volume: 17, Issue:5

    Topics: 4-Aminopyridine; Action Potentials; Adult; Amifampridine; Botulism; Female; Humans; Neuromuscular Bl

2013

Other Studies

1 other study available for amifampridine and Neuromuscular Blockade

ArticleYear
Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C.
    The European journal of neuroscience, 2007, Volume: 25, Issue:9

    Topics: 4-Aminopyridine; Amifampridine; Animals; Botulinum Toxins; Botulinum Toxins, Type A; Drug Resistance

2007